GL1X · GenesisL1 explorer

MolNFT v1 · #98219 · protein

Understanding extradiol dioxygenase mechanism in NAD+ biosynthesis by viewing catalytic intermediates - ligand-free structure

4L2N · 3-hydroxyanthranilate 3,4-dioxygenase: “Understanding extradiol dioxygenase mechanism in NAD+ biosynthesis by viewing catalytic intermediates…”. X-ray diffraction, 2 ligands (FE2, CL), 2 pockets (best druggability 0.74). MolNFT v1…

PDB
4L2N
Type
protein
Length
174 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
3-hydroxyanthranilate 3,4-dioxygenase
EC
1.13.11.6
UniProt
Q1LCS4
Ligands
FE2, CL
Pockets
2 · best druggability 0.74

Structure

x-ray diffraction · 1 distinct chain · 15% helix, 37% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A3-hydroxyanthranilate 3,4-dioxygenase (EC 1.13.11.6)protein17415% helix, 37% strandQ1LCS4

Ligands and binding sites

  • FE2 · Fe (II) ion · metal · 2 copies · chains A
  • CL · Chloride ion · ion · chains A
  • TRS · 2-amino-2-hydroxymethyl-propane-1,3-diol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14890.740.8347FE2, CL
2510.250.7317empty

Compared structures

  • 4L2N · Understanding Extradiol Dioxygenase Mechanism in NAD+ Biosynthesis by Viewing Catalytic… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q1LCS4 · AlphaFold monomer V2.0 prediction for 3-hydroxyanthranilate 3,4-dioxygenase (Q1LCS4) · a predicted model of the same protein · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.